COMPASS Pathways (CMPS)
(Delayed Data from NSDQ)
$4.34 USD
-0.01 (-0.23%)
Updated Aug 1, 2025 04:00 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, COMPASS Pathways PLC Sponsored ADR has a market cap of $416.39M, which represents its share price of $4.34 multiplied by its outstanding shares number of 95.94M. As a small-cap company, CMPS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CMPS 4.34 -0.01(-0.23%)
Will CMPS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CMPS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CMPS
COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know
CMPS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CMPS
Compass Pathways: Overly Confident Management Or Overly Skeptical Market
Compass Pathways (CMPS) Rating Maintained at Buy by Canaccord Genuity | CMPS Stock News
Compass Pathways PLC (CMPS) Q2 2025 Earnings Call Highlights: Clinical Success and Strategic ...
Q2 2025 Compass Pathways PLC Earnings Call Transcript
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks